Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Wegovy: New clinical trial says this weight-loss medication sheds more pounds This story was originally featured on Fortune.com
are changing peoples lives
Semaglutide Compound Semaglutide Compound (Subsema) is a state-of-the-art, water-free formulation designed for under-the-tongue administration, making it easier for medicines to be absorbed by the body
Source: Jastreboff et al., NEJM 2023 TRIUMPH-4 Phase 3 (68 weeks, 445 participants) Phase 2 Type 2 Diabetes Trial (36 weeks, 281 participants) In the type 2 diabetes population, weight loss was lower than in the obesity trial which is consistent with the pattern seen across all GLP-1 drugs
US$ 25.71
US$ 23.06
US$ 27.12
US$ 25.05
US$ 29.74
